Provexis plc (AIM:PXS)
0.9000
+0.0550 (6.51%)
Dec 31, 2025, 12:35 PM GMT+1
Provexis Market Cap
Provexis has a market cap or net worth of 21.11 million as of December 31, 2025. Its market cap has increased by 77.37% in one year.
Market Cap
21.11M
Enterprise Value
20.06M
Revenue
871.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
Market Cap Chart
Since September 7, 2005, Provexis's market cap has increased from 2.24M to 21.11M, an increase of 841.60%. That is a compound annual growth rate of 11.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 21.11M | 33.33% |
| Dec 31, 2024 | 15.83M | 9.84% |
| Dec 29, 2023 | 14.42M | -10.34% |
| Dec 30, 2022 | 16.08M | -6.76% |
| Dec 31, 2021 | 17.24M | -2.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.85B |
| GSK plc | 73.21B |
| Haleon | 33.38B |
| Smith & Nephew | 10.52B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.79B |
| Genus | 1.74B |